dr. o'connor discusses regorafenib dosing in mcrc
Published 5 years ago • 27 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
1:28
dr. o’connor on real-world results with regorafenib in mcrc
-
3:53
regorafenib in colorectal cancer: optimizing the dose
-
2:08
dr. becerra discusses regorafenib dosing in metastatic crc
-
5:37
starting dose and side effects with regorafenib in mcrc
-
5:31
practical advice for using regorafenib
-
3:18
a dose-escalation study of regorafenib in mcrc
-
1:21
dr. bekaii-saab discusses regorafenib use in mcrc
-
0:58
dr. kim reviews studies investigating regorafenib in mcrc
-
1:04
dr. randall holcombe discusses regorafenib for metastatic colorectal cancer
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
1:25
treating crc with regorafenib in latin america
-
1:08
dr. bendell on fda approval of regorafenib in liver cancer
-
1:46
dr. udit verma on regorafenib in patients with mcrc
-
9:34
regorafenib in colorectal cancer
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
8:18
the optimal dosing strategy for regorafenib in mcrc
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
7:08
the regorafenib dose optimization study